1. Decline in pneumococcal vaccine serotype carriage, multiple-serotype carriage, and carriage density in Nepalese children after PCV10 introduction: A pre-post comparison study.
- Author
-
Kandasamy R, Gurung M, Shrestha S, Gautam MC, Kelly S, Thorson S, Ansari I, Gould K, Hinds J, Kelly DF, Murdoch DR, Pollard AJ, and Shrestha S
- Subjects
- Humans, Nepal epidemiology, Infant, Male, Female, Child, Preschool, Serotyping, Prevalence, Nasopharynx microbiology, Pneumococcal Vaccines administration & dosage, Pneumococcal Vaccines immunology, Streptococcus pneumoniae classification, Streptococcus pneumoniae isolation & purification, Streptococcus pneumoniae immunology, Streptococcus pneumoniae genetics, Carrier State epidemiology, Carrier State microbiology, Pneumococcal Infections prevention & control, Pneumococcal Infections epidemiology, Pneumococcal Infections microbiology, Serogroup
- Abstract
Background: Carriage studies are an efficient means for assessing pneumococcal conjugate vaccine effect in settings where pneumococcal disease surveillance programmes are not well established. In this study the effect of 10-valent pneumococcal conjugate vaccine (PCV10) introduction on pneumococcal carriage and density among Nepalese children using a bacterial microarray and qPCR was examined., Methods: PCV10 was introduced into the Nepalese infant immunisation schedule in August 2015. Nasopharyngeal swabs were collected from healthy Nepalese children in Kathmandu between April 2014 and December 2021. Samples were plated on blood agar, incubated overnight, and DNA extracted from plate sweeps. Pneumococcal serotyping was done using the Senti-SPv1.5 microarray (BUGS Bioscience, UK). DNA was extracted from swab media and qPCR performed for pneumococcal autolysin (lytA)., Results: A significant decline in prevalence of PCV10 serotypes was observed when comparing pre-PCV10 with post-PCV10 collection periods (36.5 %, 454/1244 vs 10.3 %, 243/2353, p < 0.0001). Multiple-serotype carriage was also observed to significantly decline when comparing pre-PCV10 with post-PCV10 periods (31.4 %, 390/1244 vs 22.2 %, 522/2353, p < 0.0001). Additionally, a significant decline in median pneumococcal density was observed when comparing pre-PCV10 with post-PCV10 periods (3.3 vs 3.25 log10 GE/ml, p = 0.0196)., Conclusions: PCV10 introduction was associated with reduced, prevalence of all PCV10 serotypes, multiple serotype carriage, and pneumococcal carriage density., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Andrew J Pollard reports financial support was provided by GAVI Alliance. Rama Kandasamy reports a relationship with National Health and Medical Research Council that includes: funding grants. Rama Kandasamy reports a relationship with Sanofi that includes: funding grants. AJP is chair of the UK Joint Committee on Vaccination and Immunisation and was a member of WHOs SAGE while this study was being conducted. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF